{"id":18764,"date":"2023-05-22T12:33:18","date_gmt":"2023-05-22T07:03:18","guid":{"rendered":"https:\/\/www.moneyworks4me.com\/investmentshastra\/?p=18764"},"modified":"2023-05-22T12:38:11","modified_gmt":"2023-05-22T07:08:11","slug":"q4fy23-result-updates-19-may-2023","status":"publish","type":"post","link":"https:\/\/www.moneyworks4me.com\/investmentshastra\/q4fy23-result-updates-19-may-2023\/","title":{"rendered":"Q4FY23 Result Updates \u2013 19 May 2023"},"content":{"rendered":"

Dear Readers,<\/p>\n

Welcome to our weekly company result update note. We understand the importance of staying up-to-date with the latest financial developments of the companies you have invested in. That\u2019s why we are committed to providing you with short and insightful information about the earnings and performance of the companies in our coverage.<\/p>\n

In addition to the weekly company result update, after the end of the earnings season, we will also be sending you a quarterly sector result review. This will give you a broader understanding of how these sectors are performing and help you make informed decisions about your investments.<\/p>\n

SBI<\/h2>\n
\n\n\n\n\n\n\n\n
\u00a0<\/td>\nQ4FY23<\/strong><\/td>\n% Change YoY<\/strong><\/td>\nComments<\/strong><\/td>\n<\/tr>\n
Advances<\/strong><\/td>\n31,99,269<\/strong><\/td>\n17.0%<\/strong><\/td>\n\u00a0<\/td>\n<\/tr>\n
Deposits<\/strong><\/td>\n44,23,777<\/strong><\/td>\n9.2%<\/strong><\/td>\n\u00a0<\/td>\n<\/tr>\n
Net Interest Income (NII)<\/strong><\/td>\n40,392.5<\/strong><\/td>\n29.5%<\/strong><\/td>\nNIM at 3.84%<\/strong><\/td>\n<\/tr>\n
Gross Non-Performing Asset (GNPA)<\/strong><\/td>\n2.78%<\/strong><\/td>\n-118 bps<\/strong><\/td>\n\u00a0<\/td>\n<\/tr>\n
Profit after tax (PAT)<\/strong><\/td>\n16,694.5<\/strong><\/td>\n83.2%<\/strong><\/td>\n\u00a0<\/td>\n<\/tr>\n<\/tbody>\n<\/table><\/div>\n

Results were good on account of GNPA improvement.<\/p>\n

Check, 10-Year X-ray Now!<\/a><\/p>\n

Cipla<\/h2>\n
\n\n\n\n\n\n\n
\n

\u00a0<\/p>\n<\/td>\n

\n

Q4FY23<\/strong><\/p>\n<\/td>\n

\n

YOY(%)<\/strong><\/p>\n<\/td>\n

\n

Comment<\/strong><\/p>\n<\/td>\n<\/tr>\n

Revenue Net<\/strong><\/td>\n5,739<\/strong><\/td>\n9.1<\/strong><\/td>\nDomestic formulation sales grew by 3.5% YoY<\/strong><\/td>\n<\/tr>\n
EBITDA<\/strong><\/td>\n1,174<\/strong><\/td>\n56.6<\/strong><\/td>\n\u00a0<\/td>\n<\/tr>\n
EBITDA Margin<\/strong><\/td>\n20.5%<\/strong><\/td>\n620<\/strong><\/td>\n\u00a0<\/td>\n<\/tr>\n
PAT<\/strong><\/td>\n704<\/strong><\/td>\n64.4<\/strong><\/td>\n\u00a0<\/td>\n<\/tr>\n<\/tbody>\n<\/table><\/div>\n

Adjusted for COVID, growth was 14% YoY led by momentum across a portfolio of the One-India business. US sales came in at $204mn. International markets grew by 7% YoY, while SAGA reported a 13% decline. API saw a decline of 3% YoY.<\/p>\n

At Par Result.<\/p>\n

Check, 10-Year X-ray Now!<\/a><\/p>\n

ITC<\/h2>\n
\n\n\n\n\n\n\n
\u00a0<\/td>\nQ4FY23<\/strong><\/td>\nYoY(%)<\/strong><\/td>\nComments<\/strong><\/td>\n<\/tr>\n
Revenue Net<\/strong><\/td>\n16,150<\/strong><\/td>\n5.5<\/strong><\/td>\nFMCG revenue grew by 19.4% to 4,945 Cr<\/strong><\/td>\n<\/tr>\n
EBITDA<\/strong><\/td>\n6,209<\/strong><\/td>\n18.9<\/strong><\/td>\n\u00a0<\/td>\n<\/tr>\n
EBITDA Margin<\/strong><\/td>\n38.45%<\/strong><\/td>\n626bps<\/strong><\/td>\n\u00a0<\/td>\n<\/tr>\n
PAT<\/strong><\/td>\n5087<\/strong><\/td>\n21.4<\/strong><\/td>\n\u00a0<\/td>\n<\/tr>\n<\/tbody>\n<\/table><\/div>\n

Good Result on account of increase in revenue and improvement in Margin across all segments.<\/p>\n

Check, 10-Year X-ray Now!<\/a><\/p>\n

Advanced Enzyme<\/h2>\n
\n\n\n\n\n\n\n
\n

\u00a0<\/p>\n<\/td>\n

\n

Q4FY23<\/strong><\/p>\n<\/td>\n

\n

YOY (%)<\/strong><\/p>\n<\/td>\n

\n

Comment<\/strong><\/p>\n<\/td>\n<\/tr>\n

Revenue<\/strong><\/td>\n139<\/strong><\/td>\n5.3<\/strong><\/td>\nThe Human Nutrition segment, which contributes ~63% to overall revenue and is even higher in terms of profit, continued to witness weakness on account of recessionary trends in the USA and inventory pile-up at the customers\u2019 end. Ex-Human Nutrition, the portfolio grew by 13% YoY in 4QFY23.<\/strong><\/td>\n<\/tr>\n
EBITDA<\/strong><\/td>\n44<\/strong><\/td>\n9.5<\/strong><\/td>\n\u00a0<\/td>\n<\/tr>\n
EBITDA Margin<\/strong><\/td>\n31.8%<\/strong><\/td>\n122bps<\/strong><\/td>\n\u00a0<\/td>\n<\/tr>\n
PAT<\/strong><\/td>\n32<\/strong><\/td>\n27<\/strong><\/td>\n\u00a0<\/td>\n<\/tr>\n<\/tbody>\n<\/table><\/div>\n

At Par Result, US business to drive forward margins.<\/p>\n

Check, 10-Year X-ray Now!<\/a><\/p>\n

Amber Enterprises<\/h2>\n
\n\n\n\n\n\n\n
\n

\u00a0<\/p>\n<\/td>\n

\n

Q4FY23<\/strong><\/p>\n<\/td>\n

\n

YOY (%)<\/strong><\/p>\n<\/td>\n

\n

Comment<\/strong><\/p>\n<\/td>\n<\/tr>\n

Revenue<\/strong><\/td>\n3003<\/strong><\/td>\n55<\/strong><\/td>\nLed by an uptick in demand for RAC & components coupled with new customer additions.<\/strong><\/td>\n<\/tr>\n
EBITDA<\/strong><\/td>\n204<\/strong><\/td>\n62.4<\/strong><\/td>\n\u00a0<\/td>\n<\/tr>\n
EBITDA Margin<\/strong><\/td>\n6.8%<\/strong><\/td>\n31bps<\/strong><\/td>\nGross margin remained flat YoY mainly due to a change in product mix. However, better operating leverage resulted in an<\/strong>\n

EBITDA margin improvement<\/strong><\/p><\/td>\n<\/tr>\n

PAT<\/strong><\/td>\n108<\/strong><\/td>\n82.3<\/strong><\/td>\n\u00a0<\/td>\n<\/tr>\n<\/tbody>\n<\/table><\/div>\n

Good Result driven by margin improvement.<\/p>\n

Check, 10-Year X-ray Now!<\/a><\/p>\n

Kajaria Ceramics<\/h2>\n
\n\n\n\n\n\n\n
\n

\u00a0<\/p>\n<\/td>\n

\n

Q4FY23<\/strong><\/p>\n<\/td>\n

\n

YOY (%)<\/strong><\/p>\n<\/td>\n

\n

Comment<\/strong><\/p>\n<\/td>\n<\/tr>\n

Revenue ( Consolidated)<\/strong><\/td>\n1,205<\/strong><\/td>\n9<\/strong><\/td>\n\u00a0<\/td>\n<\/tr>\n
EBITDA<\/strong><\/td>\n176<\/strong><\/td>\n6<\/strong><\/td>\n\u00a0<\/td>\n<\/tr>\n
EBITDA Margin<\/strong><\/td>\n14.60%<\/strong><\/td>\n-46bps<\/strong><\/td>\nImprovement in EBITDA margin of 240bps on QOQ basis on account of decline in gas prices and cost optimization initiative.<\/strong><\/td>\n<\/tr>\n
PAT<\/strong><\/td>\n108<\/strong><\/td>\n13<\/strong><\/td>\n\u00a0<\/td>\n<\/tr>\n<\/tbody>\n<\/table><\/div>\n

The decent result on account of easing in input costs.<\/p>\n

Check, 10-Year X-ray Now!<\/a><\/p>\n

Bank of Baroda<\/h2>\n
\n\n\n\n\n\n\n\n
\u00a0<\/td>\nQ4FY23<\/strong><\/td>\n% Change YoY<\/strong><\/td>\nComments<\/strong><\/td>\n<\/tr>\n
Advances<\/strong><\/td>\n9,69,548<\/strong><\/td>\n18.5%<\/strong><\/td>\nInternational advances grew by 29.9% to 173,988 Cr<\/strong><\/td>\n<\/tr>\n
Deposits<\/strong><\/td>\n12,03,688<\/strong><\/td>\n15.1%<\/strong><\/td>\n\u00a0<\/td>\n<\/tr>\n
Net Interest Income (NII)<\/strong><\/td>\n11,525<\/strong><\/td>\n33.8%<\/strong><\/td>\nNIM at 3.53%<\/strong><\/td>\n<\/tr>\n
Gross Non-Performing Asset (GNPA)<\/strong><\/td>\n3.79%<\/strong><\/td>\n-282 bps<\/strong><\/td>\n\u00a0<\/td>\n<\/tr>\n
Profit after tax (PAT)<\/strong><\/td>\n4,775<\/strong><\/td>\n168.4%<\/strong><\/td>\n\u00a0<\/td>\n<\/tr>\n<\/tbody>\n<\/table><\/div>\n

Results were good, with solid fundamentals on all metrics.<\/p>\n

Check, 10-Year X-ray Now!<\/a><\/p>\n

Bharti Airtel<\/h2>\n
\n\n\n\n\n\n
\u00a0<\/td>\nQ4FY23<\/strong><\/td>\n% Change YoY<\/strong><\/td>\nComments<\/strong><\/td>\n<\/tr>\n
Revenue<\/strong><\/td>\n36,009<\/strong><\/td>\n14.3%<\/strong><\/td>\nARPU at 193, Enterprise segment grew by 14.5% to 4,785 Cr, 7.4 Mn 4G subscribers added<\/strong><\/td>\n<\/tr>\n
EBITDA<\/strong><\/td>\n18,806<\/strong><\/td>\n16.6%<\/strong><\/td>\nEBITDA margin at 52.2%<\/strong><\/td>\n<\/tr>\n
PAT<\/strong><\/td>\n3,005<\/strong><\/td>\n49.7%<\/strong><\/td>\n\u00a0<\/td>\n<\/tr>\n<\/tbody>\n<\/table><\/div>\n

Stable results driven by growth in subscribers & enterprise segment.<\/p>\n

Check, 10-Year X-ray Now!<\/a><\/p>\n

Quess Corp Limited<\/h2>\n
\n\n\n\n\n\n\n
\n

Rs (Cr)<\/strong><\/p>\n<\/th>\n

\n

Q4FY23<\/strong><\/p>\n<\/th>\n

\n

YoY(%)<\/strong><\/p>\n<\/th>\n

\n

Comment<\/strong><\/p>\n<\/th>\n<\/tr>\n

Revenue ( Consolidated)<\/strong><\/td>\n4,440<\/strong><\/td>\n17<\/strong><\/td>\nDriven by WFM (up 16%), OAM (up 19%), and GTS (up 20%).<\/strong><\/td>\n<\/tr>\n
EBITDA<\/strong><\/td>\n152<\/strong><\/td>\n-18<\/strong><\/td>\n\u00a0<\/td>\n<\/tr>\n
EBITDA Margin<\/strong><\/td>\n3.42%<\/strong><\/td>\n-146bps<\/strong><\/td>\nDue to investments in Product Led Business.<\/strong><\/td>\n<\/tr>\n
PAT<\/strong><\/td>\n30<\/strong><\/td>\n-61<\/strong><\/td>\n\u00a0<\/td>\n<\/tr>\n<\/tbody>\n<\/table><\/div>\n

At Par Result.<\/p>\n

Check, 10-Year X-ray Now!<\/a><\/p>\n

Container Corporation<\/h2>\n
\n\n\n\n\n\n
\u00a0<\/td>\nQ4FY23<\/strong><\/td>\n% Change YoY<\/strong><\/td>\nComments<\/strong><\/td>\n<\/tr>\n
Revenue<\/strong><\/td>\n2,184<\/strong><\/td>\n6.2%<\/strong><\/td>\n\u00a0<\/td>\n<\/tr>\n
EBITDA<\/strong><\/td>\n451<\/strong><\/td>\n8.1%<\/strong><\/td>\nEBITDA margin at 20.6%<\/strong><\/td>\n<\/tr>\n
PAT<\/strong><\/td>\n279<\/strong><\/td>\n7.1%<\/strong><\/td>\n\u00a0<\/td>\n<\/tr>\n<\/tbody>\n<\/table><\/div>\n

Subpar results on account of muted EXIM volumes.<\/p>\n

Check, 10-Year X-ray Now!<\/a><\/h2>\n

CreditAccess Grameen<\/h2>\n
\n\n\n\n\n\n\n
\u00a0<\/td>\nQ4FY23<\/strong><\/td>\n% Change YoY<\/strong><\/td>\nComments<\/strong><\/td>\n<\/tr>\n
Advances<\/strong><\/td>\n21,031<\/strong><\/td>\n26.7%<\/strong><\/td>\n\u00a0<\/td>\n<\/tr>\n
Net Interest Income (NII)<\/strong><\/td>\n690<\/strong><\/td>\n34.2%<\/strong><\/td>\nNIM at 12.2%<\/strong><\/td>\n<\/tr>\n
Gross Non-Performing Asset (GNPA)<\/strong><\/td>\n1.21%<\/strong><\/td>\n-170 bps<\/strong><\/td>\n\u00a0<\/td>\n<\/tr>\n
Profit after tax (PAT)<\/strong><\/td>\n296<\/strong><\/td>\n86%<\/strong><\/td>\n\u00a0<\/td>\n<\/tr>\n<\/tbody>\n<\/table><\/div>\n

A solid set of results with improving metrics on all parameters.<\/p>\n

Check, 10-Year X-ray Now!<\/a><\/p>\n

\"core<\/a><\/p>

Best Stocks From<\/figcaption><\/figure>\n\n

All Weather Alpha Case<\/a>\u00a0\u00a0Screener<\/a> Alpha Cases<\/a> \u00a0Business Houses Group<\/a><\/p>\n

\n

\"\" <\/a> \"\" <\/a><\/p>\n

Join our Telegram Channel:<\/strong>
\nStock Investing<\/a>
\nMutual Fund Investing<\/a><\/div>\n

\u00a0<\/p>\n

\"\"<\/a>
\nJoin our Telegram Channel:<\/strong>
\nStock Investing<\/a>
\nMutual Fund Investing<\/a><\/div>\n
\n\n
\"Need<\/div>
Need help on Investing? And more\u2026.Puchho Befikar<\/figcaption><\/figure>\n

<\/i><\/b>Why MoneyWorks4me<\/a> | Call: 020 6725 8333<\/a> | Ebook<\/a>\u00a0| WhatsApp: 9860359463<\/a><\/p>\n

*<\/strong>Investments in the securities market are subject to market risks. Read all the related documents carefully before investing.<\/p>\n

*Disclaimer:<\/strong> The securities quoted are for illustration only and are not recommendatory<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Welcome to our weekly company result update note. We understand the importance of staying up-to-date with the latest financial developments of the companies you have invested in.<\/p>\n","protected":false},"author":15,"featured_media":18765,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_is2025_no_summary":false,"footnotes":""},"categories":[1166,1182],"tags":[1530,83,1529,1531,1526],"class_list":["post-18764","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-analyst-corner","category-mw4me-outlook","tag-quarterly-result-update","tag-stock-market","tag-stock-market-update","tag-stock-news","tag-weekly-result-update"],"_links":{"self":[{"href":"https:\/\/www.moneyworks4me.com\/investmentshastra\/wp-json\/wp\/v2\/posts\/18764","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.moneyworks4me.com\/investmentshastra\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.moneyworks4me.com\/investmentshastra\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.moneyworks4me.com\/investmentshastra\/wp-json\/wp\/v2\/users\/15"}],"replies":[{"embeddable":true,"href":"https:\/\/www.moneyworks4me.com\/investmentshastra\/wp-json\/wp\/v2\/comments?post=18764"}],"version-history":[{"count":0,"href":"https:\/\/www.moneyworks4me.com\/investmentshastra\/wp-json\/wp\/v2\/posts\/18764\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.moneyworks4me.com\/investmentshastra\/wp-json\/wp\/v2\/media\/18765"}],"wp:attachment":[{"href":"https:\/\/www.moneyworks4me.com\/investmentshastra\/wp-json\/wp\/v2\/media?parent=18764"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.moneyworks4me.com\/investmentshastra\/wp-json\/wp\/v2\/categories?post=18764"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.moneyworks4me.com\/investmentshastra\/wp-json\/wp\/v2\/tags?post=18764"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}